Covıd-19 and Pregnancy: Single Center Experience With 167 Pregnancies

Authors

  • Korucuoglu U Associate Professor, Tobb-Etu University Hospital

DOI:

https://doi.org/10.47672/ajhmn.1498

Keywords:

COVID, Pregnancy, Prevalence, Preterm, Preclampsia, Cesarean

Abstract

Purpose: To describe prevalence, presenting symptoms and severity of COVID infection in our pregnant population. To determine the association between COVID infection and adverse pregnancy outcomes such as preclampsia and preterm birth. To discuss the effect of the disease on cesarean section rates. 

Methodology: This study included retrospective analysis of 167 pregnancies complicated with COVID infection in a single center between March 2020 and April 2022.

Findings: Prevalence of COVID infection was 18,1% (167/925) in our population. Most common presenting symptom was fever with a rate of 61,1% (102 of 167 pregnancies). Second most common symptom was cough with a rate of 52,7% (88 of 167 pregnancies). Three patients have been hospitalized for severe infection (1.8%). None of these patients required admission to the intensive care unit or mechanical ventilation. Eight patients delivered before 37 weeks of pregnancy resulting in a preterm rate of 4,8%. None of these 167 pregnancies were complicated with preclampsia. Forty-two of the 167 deliveries were performed by vaginal route, resulting in a cesarean section rate of 74,9%. This rate varied between 35 to 50% during years in our center before pandemics.  

Recommendation: Our findings do not match with previously published data, and reveal a more benign course during pregnancy. These results are expected to decrease the anxiety of pregnant women diagnosed with COVID and shed light to management of future infections.

 

Downloads

Download data is not yet available.

Author Biography

Korucuoglu U, Associate Professor, Tobb-Etu University Hospital

 

 

References

Edlow AG, Li JZ, Collier AY, et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open 2020; 3:e2030455.

Mofenson LM, Idele P, Anthony D et al. The evolving epidemiologic and clinical Picture of SARS-CoV-2 and COVID-19 disease in children and young people, 2020.

Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470-3.

Wastnedge EAN, Reynolds RM, van Boeckel SR, et al. Pregnancy and COVID-19. Physiol Rev 2021;101:303-18.

Wei SQ, Blodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancyoutcomes: a systematic review and meta-analysis. CMAJ 2021; 193: E540-8.

World Health Organization. Definition and categorization of the timing of mother-to-child transmission of SARS-CoV 2 scientific brief, 8 February 2021.

Zambrano LD, Elington S, Strid P, et al. Update: characteristics of symptomatic women of reproductive age with laboratory confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 164 1-7.

Downloads

Published

2023-06-15

How to Cite

Korucuoglu , U. (2023). Covıd-19 and Pregnancy: Single Center Experience With 167 Pregnancies. American Journal of Health, Medicine and Nursing Practice, 8(3), 54–59. https://doi.org/10.47672/ajhmn.1498